Cargando…
Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome
Autores principales: | Adam, Elisabeth H., Schmid, Benedikt, Sonntagbauer, Michael, Kranke, Peter, Zacharowski, Kai, Meybohm, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512215/ https://www.ncbi.nlm.nih.gov/pubmed/32972429 http://dx.doi.org/10.1186/s13054-020-03293-8 |
Ejemplares similares
-
FX06-COVID: Verbesserung der Oxygenierung durch FX06 in Intensivpatienten mit schweren Verläufen von COVID-19
por: Zacharowski, K.
Publicado: (2020) -
FX06 to rescue SARS-CoV-2-induced acute respiratory distress syndrome: a randomized clinical trial
por: Guérin, Emmanuelle, et al.
Publicado: (2023) -
Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION
por: Kloka, Jan, et al.
Publicado: (2022) -
COVID-19 Induced Acute Respiratory Distress Syndrome—A Multicenter Observational Study
por: Herrmann, Johannes, et al.
Publicado: (2020) -
Peptide Bβ(15-42) Preserves Endothelial Barrier Function in Shock
por: Gröger, Marion, et al.
Publicado: (2009)